SP01A

· Samaritan Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SP01A, covering 2006-10-27 to 2006-10-27. Get the full timeline:

Most recent: Clinical Trial Update: SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients [Phase 2]